# The Effectiveness of Lactoferrin in the Management of Treatment-induced Anemia

> **NCT03683810** · PHASE1 · UNKNOWN · sponsor: **Cyprus University of Technology** · enrollment: 50 (estimated)

## Conditions studied

- Anemia

## Interventions

- **DIETARY_SUPPLEMENT:** Lactoferrin
- **DRUG:** Recombinant human erythropoietin

## Key facts

- **NCT ID:** NCT03683810
- **Lead sponsor:** Cyprus University of Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-14
- **Primary completion:** 2023-01
- **Final completion:** 2023-06
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2022-09-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03683810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03683810, "The Effectiveness of Lactoferrin in the Management of Treatment-induced Anemia". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03683810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*